Bibliographic details
Neilson AR, Sieper J, Deeg M. Cost-effectiveness of etanercept in patients with severe ankylosing spondylitis in Germany. Rheumatology 2010; 49(11): 2122-2134
MeSH
Adult; Anti-Inflammatory Agents, Non-Steroidal /economics /therapeutic use; Cost-Benefit Analysis /economics; Drug Costs; Etanercept; Female; Germany; Health Care Costs; Humans; Immunoglobulin G /economics /therapeutic use; Male; Models, Theoretical; Quality of Life; Randomized Controlled Trials as Topic /economics; Receptors, Tumor Necrosis Factor /antagonists & Retrospective Studies; Severity of Illness Index; Spondylitis, Ankylosing /drug therapy /economics; inhibitors /therapeutic use